About 6,840,000 results
Open links in new tab
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
FASENRA approved in the US for eosinophilic granulomatosis with ...
FDA Approves Fasenra for Eosinophilic Granulomatosis With …
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA
FASENRA met the primary endpoint in the MANDARA Phase III …
Fasenra recommended for approval in the EU by CHMP for the …
AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis ...
FASENRA approved in the US for eosinophilic ... - Morningstar
Update on the MESSINA Phase III trial for Fasenra in eosinophilic ...
Fasenra approved in the US for eosinophilic granulomatosis with ...
- Some results have been removed